Author:
Stephanie Borst,Michael Ciliberto,Sreenath Thati Ganganna
Reference11 articles.
1. Peroxisome biogenesis disorders in the zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines;Braverman;Mol Genet Metab,2016
2. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders;Takemoto;Brain Dev,2003
3. Phytanic acid storage disease (refsum’s disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management;Weinstein;J Clin Apher,1999
4. Cholbam® and zellweger spectrum disorders: treatment implementation and management;Anderson;Orphanet J Rare Dis,2021
5. Epilepsy in peroxisomal diseases;Takahashi;Epilepsia [Internet],1997